Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Examen

NSG 3280 PATHO EXAM 3 STUDY GUIDE 2026/2027 COMPLETE QUESTIONS WITH VERIFIED CORRECT ANSWERS || 100% GUARANTEED PASS NEWEST VERSION

Puntuación
-
Vendido
-
Páginas
92
Grado
A+
Subido en
15-02-2026
Escrito en
2025/2026

NSG 3280 PATHO EXAM 3 STUDY GUIDE 2026/2027 COMPLETE QUESTIONS WITH VERIFIED CORRECT ANSWERS || 100% GUARANTEED PASS NEWEST VERSION 1. What happens to nerve tissue during ischemia? - ANSWER Nerve tissue struggles with anaerobic metabolism and is very sensitive to decreased oxygen. 2. What is ischemia? - ANSWER Cell death. 3. What is hypoxia? - ANSWER Decreased oxygen leading to mitochondrial failure and cell damage. 4. What is the main CNS neurotransmitter? - ANSWER Glutamate. 5. What effect does ischemia have on glutamate? - ANSWER Ischemia increases glutamate release. 6. What are the effects of too much glutamate? - ANSWER Increased calcium and water enter the cell, causing calcium overload and cytotoxic edema. 7. What does excessive glutamate production lead to? - ANSWER Increased production of nitrous oxide, free radical formation, and cell death. 8. Etiology of Parkinson Disease - ANSWER Idiopathic (most common); Secondary: drugs, toxins 9. Pathogenesis of Parkinson Disease - ANSWER Loss of dopaminergic neurons in substantia nigra; ↓ dopamine in basal ganglia; Lewy bodies (α synuclein); 75-80% neurons lost before symptoms. 10. Clinical Manifestations of Parkinson Disease - ANSWER Bradykinesia, Resting tremor (pill-rolling), Rigidity, Postural instability, Mask-like face, Shuffling gait, Micrographia, Dysphagia, Autonomic dysfunction 11. Treatment options for Parkinson Disease - ANSWER Levodopa + Carbidopa, Dopamine agonists, MAO-B inhibitors, Amantadine, Deep brain stimulation 12. Cure status for Parkinson Disease - ANSWER No cure. 13. Cerebral Palsy - ANSWER Permanent, nonprogressive motor disorder from early brain damage. 14. Types of Cerebral Palsy - ANSWER Spastic (most common), Dyskinetic, Ataxic, Mixed. 15. Causes of Cerebral Palsy - ANSWER Prenatal infection, Hypoxia, Trauma, Prematurity, Low birth weight. 16. Treatment options for Cerebral Palsy - ANSWER Muscle relaxants, Botox, Orthopedic surgery, Braces, Rehabilitation. 17. Hydrocephalus - ANSWER Excess CSF accumulation. 18. Obstructive Hydrocephalus - ANSWER Noncommunicating type of hydrocephalus. 19. Communicating Hydrocephalus - ANSWER Type of hydrocephalus where CSF can flow between ventricles. 20. Normal-pressure hydrocephalus (NPH) - ANSWER Type of hydrocephalus characterized by a triad of symptoms. 21. NPH triad - ANSWER Gait disturbance, urinary incontinence, dementia. 22. Treatment for Hydrocephalus - ANSWER Ventriculoperitoneal shunt and endoscopic third ventriculostomy. 23. A clinical finding consistent with a diagnosis of rheumatoid arthritis would be a. systemic manifestations of inflammation. b. localized pain in weight-bearing joints. c. reduced excretion of uric acid by the kidney. d. firm, crystallized nodules or -tophill at the affected joints. - ANSWER a. systemic manifestations of inflammation. 24. Rheumatoid arthritis is commonly associated with the presence of rheumatoid factor autoantibodies in the bloodstream. This indicates that rheumatoid arthritis is likely to be: a. caused by bacterial infection. b. an autoimmune process. c. An infective process d. Because of an enzymatic defect - ANSWER b. an autoimmune process. 25. In contrast to osteoarthritis, rheumatoid arthritis may be associated with: a. debilitating joint pain and stiffness. b. improvement in symptoms with aspirin therapy. c. changes in activities of daily living. d. systemic aching in the musculoskeletal system. - ANSWER D. systemic aching in the musculoskeletal system. 26. Systemic lupus erythematosus (SLE) is: a. rheumatic disease attributed to wear and tear on weight-bearing joints. b. septic joint inflammation and necrosis. c. unknown etiologic factors. d. autoimmune mechanisms. - ANSWER d. autoimmune mechanisms. 27. Individuals diagnosed with systemic lupus erythematosus (SLE) are at risk for developing numerous complications of various organs because of: a. excessive production of connective tissue. b. formation of osteophytes in tissues. c. immune injury to basement membranes. d. impaired tissue oxygen transport. - ANSWER c. immune injury to basement membranes.

Mostrar más Leer menos
Institución
NSG 3280 PATHO
Grado
NSG 3280 PATHO

Vista previa del contenido

NSG 3280 PATHO EXAM 3 STUDY GUIDE
2026/2027 COMPLETE QUESTIONS WITH
VERIFIED CORRECT ANSWERS ||
100% GUARANTEED PASS
<NEWEST VERSION>


1. What happens to nerve tissue during ischemia? - ANSWER ✔ Nerve tissue
struggles with anaerobic metabolism and is very sensitive to decreased
oxygen.


2. What is ischemia? - ANSWER ✔ Cell death.


3. What is hypoxia? - ANSWER ✔ Decreased oxygen leading to mitochondrial
failure and cell damage.


4. What is the main CNS neurotransmitter? - ANSWER ✔ Glutamate.


5. What effect does ischemia have on glutamate? - ANSWER ✔ Ischemia
increases glutamate release.


6. What are the effects of too much glutamate? - ANSWER ✔ Increased
calcium and water enter the cell, causing calcium overload and cytotoxic
edema.

,7. What does excessive glutamate production lead to? - ANSWER ✔ Increased
production of nitrous oxide, free radical formation, and cell death.


8. Etiology of Parkinson Disease - ANSWER ✔ Idiopathic (most common);
Secondary: drugs, toxins


9. Pathogenesis of Parkinson Disease - ANSWER ✔ Loss of dopaminergic
neurons in substantia nigra; ↓ dopamine in basal ganglia; Lewy bodies (α-
synuclein); 75-80% neurons lost before symptoms.


10.Clinical Manifestations of Parkinson Disease - ANSWER ✔ Bradykinesia,
Resting tremor (pill-rolling), Rigidity, Postural instability, Mask-like face,
Shuffling gait, Micrographia, Dysphagia, Autonomic dysfunction


11.Treatment options for Parkinson Disease - ANSWER ✔ Levodopa +
Carbidopa, Dopamine agonists, MAO-B inhibitors, Amantadine, Deep brain
stimulation


12.Cure status for Parkinson Disease - ANSWER ✔ No cure.


13.Cerebral Palsy - ANSWER ✔ Permanent, nonprogressive motor disorder
from early brain damage.


14.Types of Cerebral Palsy - ANSWER ✔ Spastic (most common), Dyskinetic,
Ataxic, Mixed.


15.Causes of Cerebral Palsy - ANSWER ✔ Prenatal infection, Hypoxia,
Trauma, Prematurity, Low birth weight.

,16.Treatment options for Cerebral Palsy - ANSWER ✔ Muscle relaxants,
Botox, Orthopedic surgery, Braces, Rehabilitation.


17.Hydrocephalus - ANSWER ✔ Excess CSF accumulation.


18.Obstructive Hydrocephalus - ANSWER ✔ Noncommunicating type of
hydrocephalus.


19.Communicating Hydrocephalus - ANSWER ✔ Type of hydrocephalus
where CSF can flow between ventricles.


20.Normal-pressure hydrocephalus (NPH) - ANSWER ✔ Type of
hydrocephalus characterized by a triad of symptoms.


21.NPH triad - ANSWER ✔ Gait disturbance, urinary incontinence, dementia.


22.Treatment for Hydrocephalus - ANSWER ✔ Ventriculoperitoneal shunt and
endoscopic third ventriculostomy.


23.A clinical finding consistent with a diagnosis of rheumatoid arthritis would
be
a. systemic manifestations of inflammation.
b. localized pain in weight-bearing joints.
c. reduced excretion of uric acid by the kidney.
d. firm, crystallized nodules or -tophill at the affected joints. - ANSWER
✔ a. systemic manifestations of inflammation.

, 24.Rheumatoid arthritis is commonly associated with the presence of
rheumatoid factor autoantibodies in the bloodstream. This indicates that
rheumatoid arthritis is likely to be:


a. caused by bacterial infection.
b. an autoimmune process.
c. An infective process
d. Because of an enzymatic defect - ANSWER ✔ b. an autoimmune
process.


25.In contrast to osteoarthritis, rheumatoid arthritis may be associated with:


a. debilitating joint pain and stiffness.
b. improvement in symptoms with aspirin therapy.
c. changes in activities of daily living.
d. systemic aching in the musculoskeletal system. - ANSWER ✔ D.
systemic aching in the musculoskeletal system.


26.Systemic lupus erythematosus (SLE) is:


a. rheumatic disease attributed to wear and tear on weight-bearing joints.
b. septic joint inflammation and necrosis.
c. unknown etiologic factors.
d. autoimmune mechanisms. - ANSWER ✔ d. autoimmune mechanisms.


27.Individuals diagnosed with systemic lupus erythematosus (SLE) are at risk
for developing numerous complications of various organs because of:
a. excessive production of connective tissue.
b. formation of osteophytes in tissues.
c. immune injury to basement membranes.

Escuela, estudio y materia

Institución
NSG 3280 PATHO
Grado
NSG 3280 PATHO

Información del documento

Subido en
15 de febrero de 2026
Número de páginas
92
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas

Temas

$15.49
Accede al documento completo:

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF


Documento también disponible en un lote

Conoce al vendedor

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
ProfBenjamin Havard School
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
685
Miembro desde
1 año
Número de seguidores
16
Documentos
3932
Última venta
2 horas hace
EXCELLENT ACHIEVERS LIBRARY

As a professional tutor, I provide exceptional assistance with homework, quizzes, and exams across various subjects, including Psychology, Nursing, Biological Sciences, Business, Engineering, Human Resource Management, and Mathematics. I am dedicated to offering high-quality support and ensuring that all work meets scholarly standards. To enhance the effectiveness of our services, I work with a team of experienced tutors to create comprehensive and effective revision materials. Together, we are committed to helping students achieve excellent grades through our collaborative efforts and expertise.

Lee mas Leer menos
3.8

138 reseñas

5
62
4
18
3
35
2
11
1
12

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes